|
|||||
|
|
Targeting EphA2 with miR‐124 mediates Erlotinib resistance in K‐RAS mutated pancreatic cancer |
|
| Authors: | Jing Du Yuanqiao He Weiquan Wu Peng Li Youwei Chen Zhiming Hu Yong Han |
| Abstract: | |
| Keywords: | EphA2 Erlotinib resistance miR‐124 pancreatic cancer |